Department of Chemical Engineering, University of California, Santa Barbara, California 93106, USA.
Mol Pharm. 2010 Dec 6;7(6):2173-84. doi: 10.1021/mp100193h. Epub 2010 Sep 24.
In vivo peptide inhibition of tumor suppressor p53 binding to the protein MDM2 is hampered by inefficient delivery of the peptide. Our approach to couple a hydrophobic lipid-like tail on the inhibitory peptide p53(14-29) allowed its intracellular delivery in vitro, in a panel of different cell lines. The constructed chimeric molecules, termed peptide amphiphiles, further self-assembled into supramolecular structures, identified as elongated wormlike micelles. Internalization of peptides occurred following micelle disassembly, partly via clathrin-mediated endocytosis of monomers. Incubation of SJSA-1 cells in hypertonic culture media, aimed to disrupt endocytic vesicles, resulted in peptide amphiphile-mediated cell death. Our results provide the basis for the construction of novel therapeutic supramolecular nanoparticles and suggest hydrophobic modification of peptides as a promising strategy for enhancing delivery of impermeable peptides.
在体内,肽抑制肿瘤抑制因子 p53 与蛋白质 MDM2 的结合受到肽递送至细胞内效率低下的阻碍。我们的方法是在抑制肽 p53(14-29)上连接一个疏水性类脂尾巴,使其能够在体外递送至一系列不同的细胞系中。构建的嵌合分子,称为肽两亲体,进一步自组装成超分子结构,鉴定为长形的蠕虫状胶束。肽的内化发生在胶束解体之后,部分通过网格蛋白介导的单体内吞作用。用旨在破坏内吞小泡的高渗培养介质孵育 SJSA-1 细胞,导致肽两亲体介导的细胞死亡。我们的结果为构建新型治疗性超分子纳米颗粒提供了基础,并表明疏水性肽修饰是增强不可渗透肽递送至细胞内的一种很有前途的策略。